Clinical Trial Update: Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is ongoing to evaluate the efficacy and safety of Xiangjurupining Capsule for hyperplasia of mammary glands; the study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperplasia of Mammary Glands

Drugs mentioned

• Xiangjurupining Capsule

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: Hyperplasia of Mammary Glands | Phase 3 | Status: RECRUITING